Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) EPS (Basic) (2010 - 2026)

Insmed (INSM) posted EPS (Basic) of -$0.06 for Q2 2026, up 91.96% on a QoQ basis from -$0.76 in Q1 2026, and up 96.41% year-over-year from -$0.03 in Q2 2025.

Analysis

Insmed (INSM) EPS (Basic) (2010 - 2026) Analysis & Trends

Insmed has reported EPS (Basic) for 17 years, with the latest figure at -$0.06 in Q2 2026.

  • On a quarterly basis, EPS (Basic) rose 96.41% year-over-year to -$0.06 in Q2 2026; TTM through Jun 2026 was -$4.03, a 26.29% increase from a year earlier, with the FY2025 full-year figure at -$6.42, down 15.17% from the prior year.
  • EPS (Basic) was -$0.06 for Q2 2026 at Insmed, up from -$0.76 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.06 in Q2 2026, with the low at -$1.94 in Q2 2024.
  • Average EPS (Basic) over 5 years is -$1.25, with a median of -$1.29 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2026: EPS (Basic) plunged 122.55% in 2023, then surged 96.41% in 2026.
  • Over 5 years, EPS (Basic) stood at -$1.3 in 2022, then retreated by 1.8% to -$1.32 in 2023, then fell by 8.38% to -$1.44 in 2024, then dropped by 14.95% to -$1.65 in 2025, then soared by 96.3% to -$0.06 in 2026.
  • The last three EPS (Basic) figures came in at -$0.06 (Q2 2026), -$0.76 (Q1 2026), and -$1.65 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 4.40
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -8.44
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 4.34
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 12.62
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 7.70
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -1.96
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.23
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 0.66
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -0.06
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn -4.31
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.06
Mar 31, 2026 -0.76
Dec 31, 2025 -1.65
Sep 30, 2025 -1.75
Jun 30, 2025 -1.70
Mar 31, 2025 -1.42
Dec 31, 2024 -1.44
Sep 30, 2024 -1.27
Jun 30, 2024 -1.94
Mar 31, 2024 -1.06
Dec 31, 2023 -1.32
Sep 30, 2023 -1.11
Jun 30, 2023 -1.78
Mar 31, 2023 -1.17
Dec 31, 2022 -1.30
Sep 30, 2022 -1.09
Jun 30, 2022 -0.80
Mar 31, 2022 -0.80
Dec 31, 2021 -1.01
Sep 30, 2021 -0.96